Arab World vs Malawi: Access to anti-retroviral drugs, male
Arab World
49.3%
in 2024
Malawi
90.0%
in 2024
Arab World rank
16th
Malawi rank
13th
Access to anti-retroviral drugs, male over time
- Arab World
- Malawi
How they compare
Malawi currently reports 90.0% against 49.3% in Arab World, a difference of 40.7%.
That makes Malawi's figure about 1.8 times Arab World's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Arab World ahead.
Arab World ranks 16th and Malawi ranks 13th of 19 groups.
Across the 3 decades both report, Arab World averaged higher in 1 and Malawi in 2.
Head to head by decade
| Decade | Arab World | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.9% | 6.3% | 0.6% | Arab World |
| 2010s | 24.3% | 55.4% | 31.1% | Malawi |
| 2020s | 44.2% | 86.8% | 42.6% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Arab World or Malawi?
- Malawi, at 90.0% against 49.3% in Arab World as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Arab World and Malawi?
- 40.7%, with Malawi ahead.
- How many years of comparable data are there for Arab World and Malawi?
- 25 years are reported by both, from 2000 to 2024.
- How do Arab World and Malawi rank globally for access to anti-retroviral drugs, male?
- Arab World ranks 16th and Malawi ranks 13th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.